'Do You Dispute Any Of These Figures?': Welch Brings Receipts To Grill RFK Jr. About TrumpRx Prices
Credibility score: 56/100 β Mixed Credibility. Several questionable claims detected. Watch with healthy skepticism.
BSmeter analyzed "'Do You Dispute Any Of These Figures?': Welch Brings Receipts To Grill RFK Jr. About TrumpRx Prices" and rated it 56/100 for credibility (a BS score of 44/100 β mixed credibility), on 2026-04-27. Its weakest claim β "Trump RX covers most common drugs, GLPs down 89%" β scored 35/100 and was flagged as sketchy. 8 claims were checked against the video transcript. Scores are produced by BSmeter's AI analysis of the transcript, not independent human verification.
Of 8 claims analyzed: 1 scored under 40, 5 between 40 and 69, and 2 at 70 or above.
Claims analyzed
RFK Jr: Charts wrong, need currency adjustment for fair comparison β Opinion (50/100)
At 0:30
Apples-to-oranges dodge β but prices are still in dollars? π
Why this score: Subjective rebuttal without specifics.
- RFK Jr claims currency adjustment needed but provides no adjusted figures or methodology.
- Welch's chart uses direct USD comparisons; no evidence RFK's adjustment flips the results.
- Debate valid, but lacks data to verify.
Original quote: β[1:25] >> We we currency and adjust the prices. [1:28] So, [1:29] >> is we currency adjust the prices? [1:33] So, we're getting the lowest prices in [1:36] the world. [1:37] >> You're So, you're saying my chart is [1:38] wrong? [1:39] >> Yeah. I'm saying it's apples and [1:41] oranges. Yeah.β
TrumpRx covers only 80 of 24,000 FDA drugs, not cheapest even in US β Solid (80/100)
At 1:58
Tiny catalog confirmed β 80 vs 24k is laughable scope π
Why this score: Number of drugs accurate per reports.
- TrumpRx launched with 43 drugs (Feb 2026), 54 by March; transcript's '80' close/updated.
- FDA approves ~24,000+ drugs total.
- Critiques note it offers pre-existing discounts, not always cheapest vs other US options.
Original quote: β[1:58] is Trump RX was sold as the cheapest [2:02] prices. Our research shows challenges [2:06] that unfortunately [2:08] another thing Trump RX isn't even the [2:11] cheapest prices in the United States. uh [2:15] it [2:18] only a small fraction of available drugs [2:20] are included. You know,β¦β
80 drugs on Trump RX out of all FDA approved β Dubious (45/100)
At 2:30
80? Web says 43 as of Feb '26 β where'd that extra 37 come from? π€β οΈ
Why this score: Number outdated or inflated.
- Web context confirms 43 drugs from 5 manufacturers as of Feb 20, 2026; no mention of 80.
- Possible confusion with 16 deals announced, but drugs listed are fewer.
- 'Vast majority not in' is fair opinion given thousands of FDA drugs exist.
Original quote: β[2:23] FDA approved drugs. 80 drugs are on [2:26] Trump RX. Literally 80 drugs. And that [2:31] obviously means that for the vast [2:33] majority of drugs, they're not even in [2:35] Trump RX.β
Trump RX ineligible for Medicare/Medicaid patients β Verified (90/100)
At 2:58
β
Spot on with the fine print
Why this score: Eligibility restrictions confirmed.
- TrumpRx for cash-paying patients only, excludes federal programs like Medicare/Medicaid/TRICARE.
- Matches web context exactly; limits access for most insured Americans.
Original quote: β[2:46] The fine you've got a coupon if you go [2:48] on the website and it tells a very [2:52] different story. A patient is not [2:54] eligible if he or she is enrolled in any [2:58] federal or state health care program [2:59] with prescription drug coverage such as [3:02] Medicaid or Medicare orβ¦β
15/16 Trump RX cos raised prices; profits $177B from $107B β OK (60/100)
At 3:58
Price hikes track with reality β but profits jump needs source β οΈπ
Why this score: Partially verifiable.
- Pharma raised prices on 350+ drugs in 2026 (median 4%), supports 'prices going up' post-deals.
- 16 companies/deals matches announcements; profit figures ($177B vs $107B) and exact 'all but one' unverifiable in web context.
- Market value +$1.3T referenced but not disputed here.
Original quote: β[4:03] that all but one of the 16 Trump RX [4:07] companies have increased prescription [4:10] drug prices since making their deals. [4:13] The prices are going up. [4:15] companies that signed deals made even [4:18] more money. You mentioned $1.3 trillion [4:20] in market value increase, but theyβ¦β
Pharma companies profits $177B, up from $107B β Dubious (45/100)
At 4:30
Big round numbers with zero receipts β which companies? ππ
Why this score: Unspecified scope makes this dubious. No mention of time frame, specific companies, or source.
- Web data shows individual pharma revenues like J&J $94B (2025), Eli Lilly $65B (2025), but no aggregate $177B vs $107B match.
- Profits β revenue; lacks verification for exact claim.
Original quote: βthose companies have made $177 billion in profits, up from $ 107 billion.β
Trump RX covers most common drugs, GLPs down 89% β Sketchy (35/100)
At 5:04
89% drop? Ozempic from $1000 to $350 is ~65%, not 89% π©π
Why this score: Exaggerated price drop percentage.
- TrumpRx.gov offers Ozempic at $350/month vs list $1000 (~65% reduction), not 89%.
- Covers select high-profile drugs like GLPs, but 'most common' unverified β web confirms focus on popular meds, not broad coverage.
- No evidence for 89% across GLPs.
Original quote: βTrump RX does not yet cover every drug. It covers the most common drugs. It's dropped the price of GLPs by 89%.β
Trump RX companies profits up $170B β Dubious (40/100)
At 5:29
Profits up $70B and they blame Trump RX? Causation much? ππ©
Why this score: Correlation misrepresented as program failure.
- Profits rose (e.g., Lilly, Novo up), but ties to GLP demand, not just TrumpRx deals.
- $170B close to earlier $177B claim, but no direct evidence linking increase *to* TrumpRx participation.
- Pharma profits booming industry-wide.
Original quote: βThe companies that have agreed to this have had increase in profits by $170 billion.β
See the full analysis with timestamps β